Equitable Holdings Inc. Buys New Shares in Rocket Lab Corporation $RKLB

Equitable Holdings Inc. purchased a new position in shares of Rocket Lab Corporation (NASDAQ:RKLBFree Report) in the 2nd quarter, Holdings Channel reports. The firm purchased 15,732 shares of the rocket manufacturer’s stock, valued at approximately $1,599,000.

A number of other large investors also recently bought and sold shares of RKLB. Meeder Asset Management Inc. acquired a new position in shares of Rocket Lab in the 2nd quarter valued at $30,000. Mcguire Capital Advisors Inc. acquired a new stake in shares of Rocket Lab during the 4th quarter worth $27,000. Keating Financial Advisory Services Inc. purchased a new position in shares of Rocket Lab in the 2nd quarter worth $39,000. Beacon Investment Advisory Services Inc. raised its position in shares of Rocket Lab by 364.0% in the 2nd quarter. Beacon Investment Advisory Services Inc. now owns 399 shares of the rocket manufacturer’s stock worth $41,000 after buying an additional 313 shares during the period. Finally, Zions Bancorporation National Association UT acquired a new position in Rocket Lab in the fourth quarter valued at $28,000. Hedge funds and other institutional investors own 71.78% of the company’s stock.

Key Stories Impacting Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

  • Positive Sentiment: Defense and space-systems demand remain important growth drivers. Rocket Lab is benefiting from its selection by Viasat to build spacecraft buses for the U.S. Space Force’s Protected Tactical SATCOM-Global program. Its HASTE hypersonic test platform is also expanding the company’s exposure to Pentagon missions, supporting the view that Rocket Lab is more than an Electron launch provider. Rocket Lab HASTE defense coverage
  • Positive Sentiment: Electron execution and analyst revisions offer potential support. Rocket Lab has reached 93 Electron launches, while some analysts have raised earnings estimates. A hammer chart pattern has also prompted bottom-fishing interest after the decline. Rocket Lab bottom-fisher coverage
  • Neutral Sentiment: Analysts remain broadly bullish, but the valuation requires strong execution. Rocket Lab carries a reported “Moderate Buy” consensus and an average price target of $110.65, but the company remains unprofitable and trades at a high valuation relative to current earnings. Its elevated beta also leaves the stock vulnerable to sharp swings.
  • Negative Sentiment: Neutron timing is the largest operational risk. Reports that the medium-lift Neutron rocket’s first launch could slip into 2027 have weakened a key investment thesis. The delay would postpone a major revenue and valuation catalyst while extending development costs. Rocket Lab Neutron timeline coverage
  • Negative Sentiment: Insider selling adds to near-term pressure. Five executives sold approximately $5.5 million of shares, including sizable sales by the CFO and COO. The transactions were made under Rule 10b5-1 plans to cover tax withholding on vested restricted stock units, reducing their significance, though no comparable insider buying was reported. Rocket Lab executive sale coverage
  • Negative Sentiment: Profitability remains a concern. Rocket Lab’s latest quarterly revenue exceeded expectations, but its $0.08-per-share loss was wider than forecast. Continued annual losses make the stock particularly sensitive to acquisition uncertainty, Neutron delays, and any slowdown in launch or defense growth.

Insider Buying and Selling

In related news, CAO Agostino Ricupati sold 669 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $69.63, for a total transaction of $46,582.47. Following the transaction, the chief accounting officer directly owned 26,863 shares of the company’s stock, valued at approximately $1,870,470.69. The trade was a 2.43% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Frank Klein sold 35,558 shares of the company’s stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $66.61, for a total value of $2,368,518.38. Following the completion of the transaction, the insider owned 925,737 shares of the company’s stock, valued at approximately $61,663,341.57. This represents a 3.70% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 3,524,214 shares of company stock valued at $309,110,848. 8.40% of the stock is owned by insiders.

Rocket Lab Stock Performance

NASDAQ:RKLB opened at $64.39 on Friday. The firm’s fifty day simple moving average is $77.80 and its 200 day simple moving average is $84.98. The company has a current ratio of 5.48, a quick ratio of 4.98 and a debt-to-equity ratio of 0.01. Rocket Lab Corporation has a twelve month low of $37.57 and a twelve month high of $151.00. The firm has a market capitalization of $38.53 billion, a price-to-earnings ratio of -238.47 and a beta of 2.60.

Rocket Lab (NASDAQ:RKLBGet Free Report) last announced its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The company had revenue of $234.07 million during the quarter, compared to analyst estimates of $231.62 million. As a group, equities research analysts expect that Rocket Lab Corporation will post -0.2 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on RKLB shares. Citizens Jmp reissued a “market outperform” rating and set a $130.00 price target on shares of Rocket Lab in a research report on Tuesday, August 11th. Piper Sandler began coverage on Rocket Lab in a report on Wednesday, July 15th. They issued a “neutral” rating and a $83.00 price objective on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rocket Lab in a research note on Friday, July 17th. Roth Capital set a $110.00 target price on Rocket Lab in a report on Tuesday, August 11th. Finally, KGI Securities raised shares of Rocket Lab from a “neutral” rating to an “outperform” rating and set a $107.00 target price for the company in a research report on Monday, July 27th. Three research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Rocket Lab currently has an average rating of “Moderate Buy” and a consensus target price of $110.65.

Check Out Our Latest Research Report on RKLB

Rocket Lab Company Profile

(Free Report)

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company’s primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company’s propulsion capabilities.

Read More

Want to see what other hedge funds are holding RKLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rocket Lab Corporation (NASDAQ:RKLBFree Report).

Institutional Ownership by Quarter for Rocket Lab (NASDAQ:RKLB)

Receive News & Ratings for Rocket Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rocket Lab and related companies with MarketBeat.com's FREE daily email newsletter.